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Maintenance of genetic stability is crucial for all organisms in order to avoid the onset
of deleterious diseases such as cancer. One of the many proveniences of DNA base
damage in mammalian cells is oxidative stress, arising from a variety of endogenous
and exogenous sources, generating highly mutagenic oxidative DNA lesions. One of
the best characterized oxidative DNA lesion is 7,8-dihydro-8-oxoguanine (8-oxo-G), which
can give rise to base substitution mutations (also known as point mutations). This
mutagenicity is due to the miscoding potential of 8-oxo-G that instructs most DNA
polymerases (pols) to preferentially insert an Adenine (A) opposite 8-oxo-G instead of
the appropriate Cytosine (C). If left unrepaired, such A:8-oxo-G mispairs can give rise to
CG→AT transversion mutations. A:8-oxo-G mispairs are proficiently recognized by the
MutY glycosylase homologue (MUTYH). MUTYH can remove the mispaired A from an
A:8-oxo-G, giving way to the canonical base-excision repair (BER) that ultimately restores
undamaged Guanine (G). The importance of this MUTYH-initiated pathway is illustrated
by the fact that biallelic mutations in the MUTYH gene are associated with a hereditary
colorectal cancer syndrome termed MUTYH-associated polyposis (MAP). In this review,
we will focus on MUTYH, from its discovery to the most recent data regarding its cellular
roles and interaction partners. We discuss the involvement of the MUTYH protein in the
A:8-oxo-G BER pathway acting together with pol λ, the pol that can faithfully incorporate
C opposite 8-oxo-G and thus bypass this lesion in a correct manner. We also outline
the current knowledge about the regulation of MUTYH itself and the A:8-oxo-G repair
pathway by posttranslational modifications (PTM). Finally, to achieve a clearer overview of
the literature, we will briefly touch on the rather confusing MUTYH nomenclature. In short,
MUTYH is a unique DNA glycosylase that catalyzes the excision of an undamaged base
from DNA.
Keywords: MUTYH, MUTYH-associated polyposis (MAP), MYH, mutY, DNA polymerase beta and lambda,
base-excision repair (BER), DNA glycosylases, 8-oxo-guanine
INTRODUCTION
Cellular DNA is constantly under attack of damaging agents, such
as reactive oxygen species (ROS), that derive from a multitude of
exogenous and endogenous sources (reviewed in Van Loon et al.,
2010). One of the main consequences of ROS impact on DNA
is the formation of 8-oxo-G, a frequent DNA lesion estimated
to arise around 1000–7000 times per cell per day (Collins, 1999;
European Standards Committee on Oxidative DNA Damage
(ESCODD), 2003; Gedik and Collins, 2005; Friedberg, 2006).
To counteract this heavy burden of 8-oxo-G lesions, a multi-
component system involving a plethora of enzymes has evolved
both in bacteria and mammals. 8-oxo-dGTP, which arises upon
oxidation of the nucleotide pool, is hydrolyzed by the enzymes
MutT/MTH1, which therefore prevent incorporation of 8-oxo-
dGTP into nascent DNA. When a C:G base pair is oxidized to
C:8-oxo-G, the enzyme Fpg (also known asMutM)/OGG can cat-
alyze the removal of 8-oxo-G from these base pairs. Furthermore,
other proteins such as the mismatch-repair pathway component
MutS/MSH2, or the Nei endonuclease VIII/NEIL1 and NEIL2
have been shown to protect the genome from the mutagenic
consequences of 8-oxo-G damage. Finally, A:8-oxo-G base pairs
are a substrate for MutY/MUTYH, which is the protein in the
focus of this review. Information on the contribution of all of the
other factors to genetic stability can be found in these detailed
reviews (Lu et al., 2006a; Tsuzuki et al., 2007).
In the syn conformation, 8-oxo-G functionally mimics the
base pairing properties of a Thymine (T), which leads to the
formation of stable A(anti):8-oxo-G(syn) Hoogsteen base pairs
(David et al., 2007). Due to this particular behavior of 8-oxo-G,
most pols often bypass 8-oxo-G lesions inaccurately by incor-
rectly inserting an A instead of the correct C, therefore giving
rise to A:8-oxo-G mismatches (Maga et al., 2007). If these A:8-
oxo-G mismatches are not repaired before the next round of
replication, they can generate CG→AT transversion mutations
that have the potential to transform cells and lead to cancer
(Greenman et al., 2007). Oxidative damage to C:G base pairs in
DNA leads to the generation of C:8-oxo-G base pairs. The major-
ity of 8-oxo-G from these base pairs is recognized and removed
from the genome by the OGG1 DNA glycosylase, which initiates
a canonical short-patch base-excision repair (SP-BER) pathway
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involving apurinic endonuclease 1 (APE1), pol β, XRCC1, and
DNA ligase III. This results in the restoration of the original
C:G base pair [see Figure 1, Dianov et al., 1998; Fortini et al.,
1999; Pascucci et al., 2002; Fromme et al., 2003 and reviewed in
Van Loon et al. (2010)]. However, a problematic situation may
arise when the replication fork encounters an 8-oxo-G. Such a
scenario can result from either a failure of OGG1 to repair all
8-oxo-G lesions before the start of replication, or from oxida-
tive stress during the S-phase. In contrast to UV-induced lesions,
for instance, that present a block to the replicative pols (reviewed
in Lehmann, 2002), 8-oxo-G is not considered a blocking lesion
per se (Shibutani et al., 1991; Mozzherin et al., 1997; Avkin and
Livneh, 2002). Nevertheless, it has been found that replicative
pols (such as the Klenow fragment of E. coli pol I, calf thymus
pol α and pol δ) show transient inhibition of chain extension 3′
to 8-oxo-G and extend promutagenic A:8-oxo-G base pairs more
efficiently than the correct C:8-oxo-G base pairs (Shibutani et al.,
1991; Einolf and Guengerich, 2001). Also, human pol δ has been
demonstrated to stall at sites of 8-oxo-G lesions (Fazlieva et al.,
2009). Very recently, we have proposed that a switch between
the replicative pol δ and the repair pol λ promotes the correct
bypass of 8-oxo-G lesions during replication (Markkanen et al.,
2012a). Nevertheless, oxidative stress in context of DNA replica-
tion can result in the generation of A:8-oxo-Gmispairs, which are
FIGURE 1 | MUTYH-initiated BER of A:8-oxo-G lesions. When ROS attack
DNA, they lead to the formation of C:8-oxo-G base pairs through oxidation of
G. Left column: These can be recognized by OGG1, which excises the
8-oxo-G and incises the resulting AP-site by β-elimination, giving rise to a
3′ddR5P and a 5′P residue. This 3′ sugar phosphate is then removed by
APE1, yielding in a 1 nucleotide gap with a 3′OH and a 5′P. Subsequently, pol
β catalyzes the insertion of a G opposite the templating C in this SP-BER
pathway, and ligation by XRCC1/DNA ligase I leads to restoration of an intact,
correctly base-paired double-stranded DNA again. Middle column: If the
C:8-oxo-G base pairs are not recognized before S-phase by OGG1, or they
arise through oxidation in S-phase, the replicative pols will often incorporate a
wrong A opposite 8-oxo-G, giving rise to A:8-oxo-G mispairs. If these are not
corrected, another round of replication will lead to a CG→AT transversion
mutation. Right column: The A:8-oxo-G base pairs can be recognized by
MUTYH, which catalyzes the excision of the wrong A from opposite 8-oxo-G,
leading to the formation of an AP site. This AP site is further processed by
APE1, which results in a 1 nt gap with 3′OH and 5′dRP moieties. The
incorporation of the correct C opposite 8-oxo-G and one more nucleotide is
performed by pol λ in collaboration with the cofactors PCNA and RP-A, thus
performing strand displacement of the downstream DNA strand. FEN1
cleaves the 5′ flap, leading to a 5′P moiety, which can be ligated by DNA
ligase I to yield an intact C:8-oxo-G containing double-stranded DNA. This
C:8-oxo-G is then again substrate for OGG1-mediated removal of 8-oxo-G
(left column).
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substrates for MUTYH. As a monofunctional DNA glycosylase,
MUTYH catalyzes the excision of the A mispaired with 8-oxo-
G. Thus, MUTYH is a unique glycosylase as far as it removes an
undamaged base from opposite a DNA lesion, instead of removing
the damaged base. The steps following MUTYH-initiated repair
of A:8-oxo-G lesions are discussed in more detail in the follow-
ing. As this review is focused on MUTYH, the interested reader
is referred to a detailed excellent review for more information on
the cellular DNA glycosylases in general (Jacobs and Schar, 2012).
DISCOVERY
MutY, along with the other 8-oxo-G repair enzymes FpG and
MutT, is phylogenetically an ancient protein, emphasizing the
importance to cope correctly and efficiently with oxidative dam-
age for living organisms (Jansson et al., 2010). MutY homologues
have been identified in many organisms, both in prokaryotes as
well as in eukaryotes. They all share the unique function of being
able to remove an A that is incorrectly paired with 8-oxo-G, G,
C, 5-hydroxyuracil (5-OH-U), or 2-hydroxyadenine (2-OH-A),
as specified later on.
DISCOVERY OF MutY IN E. coli
The first mutators in E. coli strains were described about 60 years
ago (Treffers et al., 1954) based on the observation that some
strains showed an altered antibiotic resistance. These findings
were used to engineer a systematic screening for mutators with
certain properties. Nghiem et al. used Lac− E. coli strains trans-
formed with constructs encoding for β-galactosidase, each inac-
tivated by a specific point mutation. When reverted back to Lac+
the specific base substitution reactivating the β-galactosidase
could be identified. A strain with an increase in C:G→A:T
transversion mutations revealed the so far not described locus
called mutY to be responsible for the observed mutator pheno-
type (Nghiem et al., 1988).
In addition to the mutY, another locus, called mutM, was
found to cause a change from C:G→A:T (Cabrera et al., 1988)
when mutated and was later identified to encode the for-
mamidinopyrimidine DNA glycosylase (Fpg) (Michaels et al.,
1991). Neither mutY nor mutM strains showed a very pro-
nounced phenotype on their own, but double mutant strains
expressed an extremely high mutation rate (Michaels et al.,
1992a). Mutations in mutY and mutM exclusively enhanced one
type of transversion mutation, while neither frameshifts nor dele-
tions were found, in contrast to what had been reported for other
mutators (Nghiem et al., 1988).
It had been shown that the correction of A:Gmispairs in E. coli
extracts could occur by two distinct pathways: the methylation-
dependent mutHLS mismatch-repair pathway that recognizes a
variety of mismatches and repairs the unmethylated DNA strand,
and a second methylation-independent mechanism specific to
A:G mismatches (Su et al., 1988). Analysis of the second path-
way revealed that the mutY gene product was involved in this
novel DNA repair mechanism (Au et al., 1988). Cells defective in
the mutHLS-dependent repair but proficient for mutY were still
able to prevent C:G→A:T transversion mutations, and themutY-
dependent repair was dominant if both pathways were available.
The function of the mutY gene product was finally elucidated by
purification of a protein according to its ability to repair a A:G
mismatch. The 36 kDa protein was capable of removing the mis-
paired base A from dsDNA and rendered the strand sensitive for
cleavage by apurinic/apyrimidinic endonucleases at the site of the
mismatch (Au et al., 1989). This result further underlined the
hypothesis that mutY encoded for a DNA glycosylase, termed
MutY, that initiated the repair of A:G mismatches while other
mispairs, as for example A:C, were not recognized. Further on, Su
et al. showed that MutY, with help of pol I and DNA ligase, was
able to restore specifically A:G mismatches to C:G in a sequence
independent manner (Su et al., 1988). Cloning and sequencing of
the mutY gene finally revealed that it encoded for a 350 amino
acids DNA glycosylase that could rescue the mutator phenotype
of mutY E. coli strains (Michaels et al., 1990).
DISCOVERY OF THE MAMMALIAN MutY HOMOLOG (MUTYH)
The first experiments using cell extracts showed that, in gen-
eral, humans had a repair mechanism for mismatches similar to
those of bacteria preventing the generation of mutations dur-
ing replication (Holmes et al., 1990; Thomas et al., 1991). The
analysis of human HeLa nuclear extracts revealed the existence
of two enzyme systems that could nick DNA specifically at sites
of mispaired bases (Yeh et al., 1991). One of the identified sys-
tems showed a specific substrate recognition, cleaving the DNA
at A:G mismatches and could be separated from other enzymes
by chromatography. Since this enzyme showed the same sub-
strate specificity as the bacterial MutY, Yeh et al. proposed to have
identified its human homologue (Yeh et al., 1991).
The first characterization of a mammalian homologue of
MutY was published by McGoldrick et al., who purified an
enzyme from calf thymus that was acting on A:G mismatches.
Apart from the substrate specificity they described several other
features indicating that they had indeed purified a MutY homo-
logue: An AP endonuclease activity was co-purified with the DNA
glycosylase and the antibody generated against bacterial MutY
recognized a band at the expected size and could inhibit the DNA
glycosylase activity of the purified protein (McGoldrick et al.,
1995). Based on the finding that CG→AT transversion mutations
occur often in different kinds of cancer (Hollstein et al., 1991), the
authors already hypothesized that the human MutY homologue
might be involved in cancer prevention.
A few years after the characterization of human homologue
of the 8-oxo-dGTP hydrolase MutT which removes 8-oxo-dGTP
from the nucleotide pool (Sakumi et al., 1993), Slupska et al.
succeeded in cloning and sequencing of the human mutY gene,
termed MUTYH (Slupska et al., 1996). By screening different
cDNA libraries for amino-acid sequence homologies, they iden-
tified a gene that showed 41% identity with the E. coli mutY.
The gene was 7.1 kb long, contained 15 introns and encoded
for a protein of 535 amino acids in length, which was consis-
tent with the size of the protein that had been detected in HeLa
cells (McGoldrick et al., 1995). By using in situ hybridization they
could map the gene on chromosome 1, between p32.1 and p34.3.
The current status of knowledge is that the humanMUTYH gene
codes for at least 10 different isoforms of MUTYH protein. There
are three major transcripts, α, β, and γ that differ from each
other in the 5′ end sequence and are generated through alternative
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splicing (Ohtsubo et al., 2000). The transcript α3 was found to be
the originally identified MUTYH, but so far it is not entirely clear
what the functions of the different isoforms are and to which cell
compartment they are localized, as we will discuss below in more
detail.
NOMENCLATURE OF MUTYH
Currently, literature referring to the protein product of the mam-
malian MUTYH gene is rather confusing due to a diversity of
different synonyms and writing styles that have been used over
the last years. The most commonly used names are MUTYH,
MutYH, MYH, and hMYH. Here, we propose to uniformly use
MUTYH as name for this protein in mammals in order to
simplify the literature overview, because of the following rea-
sons. Firstly, MUTYH [MutY homolog (E. coli)] is the officially
approved name for the gene fromwhichMUTYHderives (HUGO
Gene Nomenclature Committee). Secondly, the official protein
name listed by leading protein databases (UniProtKB, neXtProt,
Ensembl, and Reactome) is MUTYH. Thirdly, as the protein
derives its name from the bacterial homolog mutY that was dis-
covered first, the logical extension would be the addition of an
“H” for “homolog” at the end of the protein name, which also
leads to easy recognition of homology between MUTYH and
MutY.
FUNCTION OF MutY AND MUTYH
MutY
MutY—substrate specificity
The currently known substrates for MutY and MUTYH are sum-
marized in Table 1. Analysis of the substrate specificity for MutY
demonstrated that it acts as a glycosylase on A:G, A:8-oxo-G, A:C,
and A:8-oxo-A mismatches, always removing the undamaged A
from each substrate (Michaels et al., 1992b). Lu et al. further
refined the DNA determinants and substrate specificities for the
catalytic activity of MutY, using binding and endonuclease assays
with a variety of different A-containing mismatches, and con-
cluded that DNA sequences proximal to the mismatch as well as
specific functional groups of mismatched bases dictate the recog-
nition and catalysis by MutY (Lu et al., 1995). Moreover, while
MutY bound the A:8-oxo-Gmuch tighter than A:G, its activity on
A:8-oxo-G was weaker than on A:G mismatches. Bulychev et al.
contradicted this notion in a subsequent report stating that A:8-
oxo-G appeared to be the natural substrate for MutY, as judged
by the specificity constants and the fact that the presence of an
8-oxo-group in G increased significantly the rate of removal of A
from all tested substrates (Bulychev et al., 1996). Additionally to
A:8-oxo-G, MutY was shown to bind to G:8-oxo-Gmismatches as
well, and it was capable of removing G from this substrate (Zhang
et al., 1998). The sequence context surrounding an A:Gmismatch
was shown to also significantly influence the catalytic activity of
MutY (Sanchez et al., 2003).
8-oxo-G is chemically labile toward further oxidation
into guanidinohydantoin (Sp1), spiroiminodihydantoin (Sp2),
oxaluric acid, and urea. Delaney et al. investigated the activity of
MutY on these lesions by introducing them into single-stranded
viral genomes which were replicated in E. coli proficient or defi-
cient for MutY (Delaney et al., 2007). These lesions were found
to be equally mutagenic in terms of frequency in both genetic
Table 1 | Substrate specificities of the different MutY and MUTYH
proteins.
Protein Base pair Excised References
substrate base
MutY E. coli A:G A Michaels et al., 1992b;
Lu et al., 1995; Gogos
et al., 1996; Noll et al.,
1999; Gu and Lu, 2001
A:8-oxo-G A Michaels et al., 1992b;
Lu et al., 1995; Gogos
et al., 1996; Noll et al.,
1999; Gu and Lu, 2001
A:C A Michaels et al., 1992b
A:8-oxo-A A Michaels et al., 1992b
2-OH-A:G 2-OH-A Hashiguchi et al., 2002;
Pope and David, 2005
2-OH-A:8-oxo-G 2-OH-A Pope and David, 2005
A:FapyG A Wiederholt et al., 2003
G:8-oxo-G G Zhang et al., 1998
MutY
Th. thermophilus
A:8-oxo-G A Back et al., 2006
A:G A Back et al., 2006
G:8-oxo-G G Back et al., 2006
T:8-oxo-G T Back et al., 2006
MUTYH
S. pombe
G:8-oxo-G G Doi et al., 2005
A:8-oxo-G A Doi et al., 2005
MUTYH mouse A:8-oxo-G A Tominaga et al., 2004;
Pope and David, 2005
A:G A Pope and David, 2005
2-OH-A:G 2-OH-A Pope and David, 2005
2-OH-A:8-oxo-G 2-OH-A Pope and David, 2005
MUTYH calf A:G A McGoldrick et al., 1995;
Parker et al., 2000
A:8-oxo-G A McGoldrick et al., 1995;
Parker et al., 2000
A:C A McGoldrick et al., 1995;
Parker et al., 2000
G:8-oxo-G G Parker et al., 2000
T:8-oxo-G T Parker et al., 2000
C:8-oxo-G C Parker et al., 2000
MUTYH human A:8-oxo-G A Slupska et al., 1999;
Shinmura et al., 2000;
Gu and Lu, 2001
A:G A Slupska et al., 1999;
Shinmura et al., 2000;
Gu and Lu, 2001
2-OH-A:G 2-OH-A Ushijima et al., 2005
backgrounds and to yield similar mutation spectra, suggesting
that MutY does not play a role in the excision of these bases.
Interestingly Sp1 and Sp2 were more toxic to the cells that were
proficient in MutY.
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2-hydroxyadenine (2-OH-A) is a lesion that is induced by
Fenton-type ROS and is produced for instance by H2O2 treat-
ment of culturedmammalian cells (Jaruga andDizdaroglu, 1996).
Incorporation of 2-OH-dATP into the bacterial genome by pol
III was shown to yield slightly increased mutant frequencies in
a MutY deficient background in E. coli, suggesting that the pro-
cessing of 2-OH-A damage possibly also involves the action of
MutY (Kamiya and Kasai, 2000a). However, follow-up work by
the same authors showed that, irrespectively of the base in the
complementary strand, DNAwith 2-OH-A presented a very poor
substrate for MutY, and therefore illustrated that neither MutY
nor Fpg seemed to play a role in 2-OH-A removal from DNA
(Kamiya and Kasai, 2000b). Another result by Hashiguchi et al.
again reassessed this finding and they reported that MutY indeed
bound to 2-OH-A in duplex with G, A, or C and displayed a DNA
glycosylase activity capable of removing 2-OH-A from 2-OH-A:G
mismatches, which was dependent on the C-terminal domain of
the protein (Hashiguchi et al., 2002).
FapyG is a DNA lesion that arises from oxidative stress by ring-
fragmentation of the purine base. MutY excised A from A:FapyG
mismatches, and this reaction was faster than the removal of
A from A:G, but still slower than that from A:8-oxo-G in vitro
(Wiederholt et al., 2003).
One group reported that MutY efficiently recognized 7-deaza-
2′-deoxyadenosine (Z) and its non-polar isostere 4-methylindole-
beta-deoxynucleoside (M) opposite 8-oxo-G and G in DNA,
with a preference for M:8-oxo-G over Z:8-oxo-G mispairs
(Chepanoske et al., 2000b). This finding was contradicting a pre-
vious report, in which Z:G mispairs were neither bound nor
processed by MutY (Lu et al., 1995).
Lu et al. showed that MutY competes with and inhibits
endonuclease VIII on its natural substrate, the hydroxyurea
(hoU):A mismatch (Lu et al., 2006b).
A MutY variant from Thermus thermophilus processed A:8-
oxo-G, G:8-oxo-G as well as T:8-oxo-G and A:G mismatches,
but in contrast to other MutY variants, was shown to harbor a
bifunctional glycosylase activity (Back et al., 2006).
MutY—enzymatic activity
The cloning of E. coli MutY revealed that it shared significant
sequence homology to the bacterial endonuclease III (EndoIII),
which acts on damaged base pairs (Michaels et al., 1990). MutY
was shown to be an iron-sulfur (Fe-S) cluster protein containing
both N-glycosylase and a 3′ AP endonuclease activity (Tsai-Wu
et al., 1992). Initially there was some confusion regarding the
enzymatic activity of MutY. While some reports stated that MutY
also acted as an endonuclease on AP sites, therefore functioning
as a bifunctional glycosylase (Tsai-Wu et al., 1992; Lu et al., 1995,
1996; Gogos et al., 1996; Manuel and Lloyd, 1997), Zharkov and
Grollman showed that MutY does not harbor any AP lyase activ-
ity (Zharkov and Grollman, 1998). They hypothesized that the
previous observations for the observed AP-activity were rather
caused by heat-induced cleavage of the AP site and not due to an
actual enzymatic activity. Moreover, this report suggested that the
tight binding of MutY to its DNA substrate prevented the access
of another bacterial glycosylase, the formamidopyrimidine-DNA
glycosylase (Fpg), to the substrate. Consequently, MutY seemed
to prevent a possible generation of a DNA double-strand break
(DSB) by Fpg and thus possibly to play a role in the regulation
of BER.
MutY—catalytic mechanism
When considering the catalytic activity of MutY (or any other
DNA glycosylase), it is important to keep in mind that the
catalytic cycle can be roughly subdivided into different stages,
namely (1) recognition and binding of the enzyme to the sub-
strate, (2) hydrolysis of the N-glycosidic bond or base-excision,
and (3) dissociation of the enzyme or release of the resulting AP
site. We have tried to structure the discussion according to these
three steps in the catalytic cycle, whenever possible.
Substrate recognition. Multiple studies elucidating the contri-
butions of the different parts of the MutY protein have been
undertaken. Proteolytic digestion of MutY with thermolysin
produced two fragments, an N-terminal one of 25 kDa and a
C-terminal one of 12 kDa, respectively (Gogos et al., 1996). While
the 12 kDa fragment did not display any detectable enzymatic
activity, it was found to play an important role in the repair of
mismatched oxidized DNA, as its deletion significantly impaired
the binding and activity of MutY on A:8-oxo-G substrates, while
it did not influence binding and cleavage of A:G substrates. On
the other hand, a similar study, generating a 26 kDa N-terminal
domain of MutY by trypsin-mediated proteolysis showed that
this 26 kDa subunit was catalytically active, contained both DNA
glycosylase and AP lyase activity, and was functionally identi-
cal with the full-length protein (Manuel et al., 1996; Manuel
and Lloyd, 1997). A 14 kDa C-terminal domain of MutY (AA
1–226) was demonstrated to be the principal determinant for
8-oxo-G specificity, as its deletion remarkably enhanced the dis-
sociation of the enzyme from A:8-oxo-G and reduced the rate of
A removal from these substrates compared to A:G mismatches
(Noll et al., 1999). This was interpreted such that the C-terminal
domain facilitated A base flipping. Also, this study found that the
C-terminal domain of MutY showed homology with MutT, sug-
gesting that it might serve in 8-oxo-G recognition. Another report
supported this view by showing that the N-terminal domain
of MutY (AA 1–226) had a 18-fold lower affinity for binding
various 8-oxo-G mismatches, a reduced catalytic preference for
A:8-oxo-G over A:G mismatches and exhibited a lower inhibi-
tion on Fpg activity than the wild-type (wt) MutY (Li et al.,
2000). These results suggested that the C-terminal domain of
the protein determines its 8-oxo-G specificity and is crucial for
mutation avoidance. The C-terminal domain was then shown to
mediate additional contacts between MutY and A:8-oxo-G con-
taining substrates that are not found in interaction with A:G (Li
and Lu, 2000), thereby promoting the efficient recognition of
substrates byMutY (Chmiel et al., 2001) and also affecting the cat-
alytic activities toward A:G mismatches (Li and Lu, 2003). Taken
together, the C-terminal domain of MutY seems to contribute
substantially to the A:8-oxo-G substrate recognition.
It is still not entirely clear, how MutY is capable to effi-
ciently recognize all its substrates from among the vast amount
of undamaged base pairs. Along this line, the Fe-S cluster present
in MutY was shown to be critical for the specific recognition of
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its DNA substrate and its enzymatic activity (Porello et al., 1998a;
Golinelli et al., 1999; Chepanoske et al., 2000a). It has also been
suggested that the relative oxidation resistance of the Fe-S clus-
ter may be an important aspect to guarantee the activity of MutY
under conditions of oxidative stress (Messick et al., 2002). K142
in MutY, earlier shown to be involved in formation of tight inter-
actions with DNA, was shown to make specific contacts with
8-oxo-G, and DNA-mediated charge transport (CT) was sug-
gested as signal to promote the binding of MutY to DNA from
a distance (Boon et al., 2002). Along this line, DNA-mediated CT
led to oxidation of DNA-bound MutY, suggesting that G radicals
provide the signal to stimulate DNA repair by the redox acti-
vation of DNA repair proteins through CT (Yavin et al., 2005).
Further substantiating this idea, Boal et al. proposed that the
rapid redistribution of proteins to the sites of DNA damage was
mediated through redox activation involving the Fe-S clusters
in proteins such as MutY and EndoIII (Boal et al., 2005; Yavin
et al., 2006). A theoretical study of the DNA damage recogni-
tion by Bacillus stearothermophilus MutY proposed that the CT
from MutY to DNA through hole transfer, which is specially effi-
cient near an 8-oxo-G, leads to the stabilization of the enzyme
in a conformation required for recognition of the lesion (Lin
et al., 2008). Examination of the charge-transfer model by atomic
force microscopy further validated this concept and emphasized
the possibility that indeed repair proteins might be recruited to
DNA lesions by DNA-mediated CT in the cellular context (Boal
et al., 2009). The authors therefore proposed a model wherein
the binding of Fe-S cluster containing DNA repair proteins (such
as MutY and EndoIII) to DNA activates them toward oxidation.
First, the formation of a guanine radical oxidizes a repair pro-
tein bound to DNA and thus stabilizes the binding of this protein.
This step is followed by the binding of a second protein near the
first one. Because also this protein gets oxidized during binding
and transfers an electron to the DNA, it will induce a DNA-
mediated CT from the second to the first protein if no damage
is present in the DNA stretch between the two binding sites. This
CT leads to reduction of the first protein and thus to its release
from DNA, because in the reduced state it has a lower affin-
ity to DNA. However, if there is a DNA lesion between the two
bound proteins, the CT does not take place (it is “blocked” by the
intervening lesion). In this situation both of the proteins remain
bound and can subsequently catalyze repair steps. Through exam-
ination of CT mutants of EndoIII the group subsequently linked
the ability of a repair protein to carry out DNA CT and its ability
to localize to damaged DNA and thus further underlined their
model (Romano et al., 2011). Taken together, the role for the
Fe-S cluster as redox cofactor to search for damaged bases using
DNA-mediated CT becomes more and more substantiated and
really presents a plausible scenario to explain the mechanisms of
full-genome search for lesions.
Base-excision. Investigations into the glycosylase activity of
MutY revealed a distinctive difference in the processing of A:8-
oxo-G compared to A:G mismatches (Porello et al., 1998b).
Hydrolysis of A from opposite 8-oxo-G was at least 6-fold faster
than from the A:G mispair. Interestingly however, MutY “lin-
gered” when excising from an A:8-oxo-G base pair and released
the product with a much slower kinetic compared to the A:G sub-
strate. This delay in substrate release might protect 8-oxo-G from
being prematurely accessed and removed by other glycosylases, as
also suggested by Zharkov and Grollman (1998). A detailed study
of the active site revealed the importance of several amino acids
involved in the glycosylase as well as DNA binding activities of
MutY (Wright et al., 1999). Bifunctional glycosylases all bear a
conserved lysine residue believed to be important for the initial
nucleophilic attack in base removal near their active site, which
is lacking in their monofunctional counterparts. To yield more
insight into the role of this residue on a structural basis, Williams
et al. investigated whether insertion of such a lysine residue into
the catalytic site of MutY had any influence on its activity. Indeed,
a point-mutation at S120K generated a MutY mutant capable of
catalyzing DNA strand scission at a rate that was similar to its
A excision activity from A:G and A:8-oxo-G substrates, and also
changed it into a bifunctional glycosylase (Williams and David,
2000). This study illustrated that the basic mechanisms of mono-
and bifunctional glycosylases were quite similar. The glycosylase
activity of MutY was shown to involve a Schiff base intermedi-
ate, characteristic for other bifunctional DNA glycosylases that
catalyze a β-lyase reaction, though no β-lyase step (per se only per-
formed by bifunctional glycosylases) could be observed (Williams
andDavid, 1998). Reduction of this Schiff-base intermediate with
borohydride resulted in the formation of a covalent MutY-DNA
adduct. To identify the residues involved in this covalent complex
formation, Williams et al. constructed different MutY mutants
and identified K142 to be the primary residue for such covalent
associations (Williams andDavid, 1999). As the DNAbinding and
enzymatic activity of the K142A mutant was comparable to that
of the wt enzyme, the formation of this covalent intermediate was
not required for removal of A and was suggested to be a conse-
quence of the unusually high affinity of MutY for the product of
its glycosylase activity. Similarly, mutation of K142 to glutamine
in MutY was shown to also abrogate its ability to form a Schiff
base with DNA, while still retaining some of its catalytic activ-
ity (Zharkov et al., 2000). Interestingly, this mutation selectively
impaired the processing of A:G base pairs, but not of A:8-oxo-
G substrates, primarily by interfering with the binding to A:G
substrates, but did not impair the catalytic activity per se, again
confirming that it was not directly involved in the catalytic step.
Using unnatural substrates to elucidate the tolerance of MutY to
different modifications of the A or the 8-oxo-G in mismatches in
an E. coli-based cellular assay, it was seen that, while modification
of A was tolerated rather well, modification of 8-oxo-G resulted
in a drastic reduction of base-excision (Livingston et al., 2008).
This led to the conclusion that the presence of 8-oxo-G is critical
for MutY to recognize A:8-oxo-G mismatches in vivo to initiate
repair. D138 and Q37 are both residues that are involved in the
catalytic mechanism of MutY-mediated A removal. Interestingly,
their substitution yielded mutants with a range of different
excision activities. Studies of these mutants demonstrated that
changes which reduced the excision activity were better tolerated
and less compromising to A:8-oxo-G repair in vivo in E. coli than
those affecting the recognition of A:8-oxo-G mismatch affinity
(Brinkmeyer et al., 2012). Therefore, this report suggested that the
recognition of A:8-oxo-Gmismatches wasmore important for the
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correct repair of these duplexes than the actual glycosylase activity
per se. Interestingly, this can be reconciled with the fact that the
release of the substrate byMutY after base-excision ismuch slower
than the actual N-glycosidic activity, seemingly demonstrating
that the rate-limiting step of this enzyme is rather the identifica-
tion of its substrate than the excision step itself. Additionally, this
study also revealed which residues are critical for the selectivity
and specificity of MutY.
Substrate release. The product release rate of MutY could be
greatly enhanced by the two proteins AP-endonuclease IV and
exonuclease III, and this effect depended on the presence of the
C-terminal domain of MutY (Pope et al., 2002). Also, endonu-
clease VIII was found to promote MutY dissociation from AP:G
substrates, but not from AP:8-oxo-G, and to further process these
by βδ elimination (Lu et al., 2006b). This study also showed that
MutY interacts with endo VIII through its C-terminus and com-
petes with endo VIII on its natural substrate, the hydroxyurea
(hoU):Amismatch, thus inhibiting its activity and possibly reduc-
ing the mutagenic effects of hoU. Taken together, it seems impor-
tant that also the substrate release step is tightly regulated, in
order to orchestrate the following steps and to protect the 1-nt
gap resulting from base-excision.
Structure of MutY and the removal of adenine opposite 8-oxo-G
The most precise structure of MutY comes from studies with
Bacillus stearothemophilus (Lee and Verdine, 2009) (Figure 2).
After binding to the 8-oxo-G:A mispair MutY flips out the A from
the DNA double-helix. A water molecule is positioned between
Asp144 and Asn146 in the MutY lesion-recognition pocket of
the enzyme. Earlier studies included biochemical and compu-
tational studies on uracil DNA glycosylase (Werner and Stivers,
2000; Dinner et al., 2001) suggested that a so called dissociative
action occurs, where the cleavage of the N-glycosylic bond and
the subsequent attack of the water molecule on the C1′ (arrow
in Figure 2A) do not occur simultaneously, but rather in two
FIGURE 2 | Adenine removal by MUTYH. (A) View of the substrate adenosine interacting with catalytic residues of MUTYH. (B) Proposed glycolytic
mechanism based on the structural information of (A). Reproduced form Lee and Verdine (2009). For details see text.
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discrete steps. In addition Glu43 can adopt a so-called bifur-
cated hydrogen-bonding interaction of 2.7 and 2.8 Angströms,
respectively, with N7 of A (Figures 2A,B). These short distances
together with a protonated Glu43, provides acidity and therefore
full hydrogen bonding to the N7 of A. As indicated in Figure 2B
such a conformation favors the scission of the glycosylic bond
between A and the deoxyribose. A similar structure has also been
identified for human MUTYH, for which a fragment lacking the
first 64 amino-acids was crystalized (Luncsford et al., 2010).
The structure of MutY catalytic core revealed that the two heli-
cal domains form a positively-charged groove, positioning the
A-binding pocket at their interface (Guan et al., 1998). Also, this
study confirmed a nucleotide flipping mechanism by a substi-
tution of the Watson–Crick hydrogen bond partners by protein
atoms. Recognition of 8-oxo-G seems to occur independently
of double-stranded DNA or of an A-mismatch, and sequential
extrusion of 8-oxo-G followed by A occurs in MutY, as demon-
strated by Bernards et al. (2002). MutY has been proposed to
assemble into a dimer upon substrate binding to yield an active
form of the enzyme (Wong et al., 2003). This idea was further
substantiated by a study that suggested a model for MutY binding
of the mismatched DNA that involves scanning of the DNA by
one molecule which enhances binding of second MutY molecule
upon encountering an A:8-oxo-G mismatch (Lee et al., 2004).
Kinetically, it has been suggested that the release of A happens
fast, while the rate-limiting step was the release of the AP-site
(McCann and Berti, 2003). Further investigations into the transi-
tion state structure of MutY showed that the irreversible breakage
of the N-glycosidic bond could not take place until a H2O atom
was present and that the enzyme stabilized the excision site after
excision (McCann and Berti, 2008). Recently, a two-step reaction
was proposed to be the basis of the catalytic activity of MutY, as
opposed to the three-step mechanism proposed before (Tiwari
et al., 2011).
Investigations of the roles of the different H2O molecules
involved in catalysis by MutY from B. stearothermophilus and
E. coli suggested that E43 andN7may be important factors for the
activity of MutY (Brunk et al., 2012). Further insight into the roles
of the substrate A residues N7 and N3 during catalytic excision by
MutY have been gained recently (Michelson et al., 2012).
MutY in living cells
In E. coli, MutY was shown to be co-transcribed as first gene of
a part of a large operon, together with Fpg, the bacterial DNA
glycosylase which removes 8-oxo-G from the DNA (Gifford and
Wallace, 1999). This further emphasized the involvement ofMutY
in the repair of 8-oxo-G base pairs in an interplay with Fpg
and thus in the response to oxidative DNA damage. Somewhat
surprisingly at first glance, oxidative stress down-regulated the
activity of MutY by 70% as well as its mRNA levels, and in con-
trary it was inducedmore than 2-fold under anaerobic conditions
(Yoon et al., 2003). This negative regulation of MutY was medi-
ated by the regulatory genes fur, fnr and arcA. These results were
explained with the idea that MutY activity had to be restrained
when increased incorporation of 8-oxo-dGTP could possibly take
place, which is during times of oxidative stress. This is impor-
tant, because 8-oxo-dGTP could be inserted opposite a correct
templating A, which might erroneously get excised by the action
ofMutY, thus actually acting promutagenic in this scenario instead
of protecting from mutations taking place.
Screening for mutator loci leading to GC→CG transversions
in E. coli, Zhang et al. found that inactivation of MutY led to accu-
mulation of these mutations (Zhang et al., 1998). As mentioned
above, they showed that MutY bound to G:8-oxo-G mismatches
and was capable of removing G from the G:8-oxo-G mispair.
To analyze the impact of mutT, mutM (which encodes the
Fpg DNA glycosylase that removes 8-oxo-G from C:8-oxo-G base
pairs in bacteria), andmutY on the mutational spectra, following
considerations have to be taken into account. In the context of 8-
oxo-G and 8-oxo-dGTP (1) CG→AT mutations can arise either
from oxidation of C:G to C:8-oxo-G or from incorporation of
8-oxo-dGTP opposite C, followed by wrong incorporation of A
opposite 8-oxo-G by the replicative pols during the next round of
replication. (2) AT→CGmutations are based on incorporation of
8-oxo-dGTP opposite templating A. Analyzing different combi-
nations of mutated strains inmutT, mutY, andmutM, Fowler et al.
found that (1) mutT does not increase CG→AT transversions,
regardless of themutY andmutM background, suggesting that 8-
oxo-dGTP does not often get incorporated opposite C but rather
opposite A. (2) AT→CG transversions are reduced in mutY and
mutMmutY backgrounds, suggesting templating 8-oxo-G prefer-
entially pairs with dATP, which then is a substrate for MutY to
excise A from the A:8-oxo-G pair, followed by Fpg that removes
8-oxo-G paired with C. And finally (3) mutY and mutMmutY
decrease AT→CG mutations (arising from incorporation of 8-
oxo-dGTP opposite templating A) in a mutT wt background,
suggesting that a certain amount of 8-oxo-G gets incorporated
into DNA even in the presence of functional MutT (Fowler et al.,
2003). No strand bias in the mutation rate between leading and
lagging strand synthesis in either a mutMmutY or a mutT back-
ground could be detected in E. coli using a supF shuttle vector
(Watanabe et al., 2001). Interestingly, Bridges et al. showed that
the rate of mutation markedly increased in starved mutY mutant
E. coli, yielding CG→AT transversion mutations (Bridges et al.,
1996). This phenotype could be further enhanced by additional
mutation ofmutM, even though mutation ofmutM alone did not
cause this effect. Also, addition of catalase to the plates did not
alter the mutation rates, indicating that extracellular H2O2 was
not involved in the generation of mutations, and it was suggested
that singlet oxygen could be the source of internal DNA damage.
These findings indicated that MutY may regulate the activity of
Fpg in resting cells. Expression of MutY from a mutY-lacZ fusion
construct was shown to be enhanced under aerobic compared
to anaerobic conditions, but not to be down-regulated by nutri-
ent limitation (Notley-McRobb et al., 2002). However, in many
cases, nutrient limitation led to mutY inactivation by deletion,
suggesting it might serve as a mechanism to increase mutation
rates under these adverse conditions.
Clustered lesions, as induced by ionizing radiation, are defined
as two or more lesions formed within one to two helical turns
of the DNA. They present a challenge to the repair machinery
of the cell. An 8-oxo-G in the vicinity of an AP site was found
to retard the processing of the AP site by endo III and Fpg,
and the AP site was found to elevate the mutation frequency at
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8-oxo-G in wt, nth, fpg, and mutY deleted E. coli (Cunniffe et al.,
2007). Interestingly though, the mutation frequency in mutYfpg
null cells was reduced by the presence of the AP site, suggest-
ing that the processing of tandem lesions challenges the cellular
repair machineries. Similar findings by Noguchi et al. investigat-
ing the interplay of 1-nt-gaps and 8-oxo-G lesions in clusters in
E. coli demonstrated again, that the mutagenic potential of 8-oxo-
G depends on the presence and the position of the gap (Noguchi
et al., 2012).
MutY competed with MutS-dependent mismatch-repair when
A:C mispairs were present, especially in the presence of an
increased dCTP pool (Kim et al., 2003). In E. coli, MutY has been
shown to interact via its Fe-S cluster with the ATPase domain of
MutS, which enhanced the binding affinity of MutY to A:8-oxo-
G mismatches (Bai and Lu, 2007). MutY expression and activity
were enhanced in a mutS mutant strain, and AT→GC transver-
sions were reduced by additional mutation of mutY in a mutS
background, suggesting a cooperative effect of MutY and MutS
in repair of 8-oxo-G damage. Analysis of Bacillus subtilis revealed
that the expression of MutY increased drastically upon deletion
of mutSL operon in starved cells, possibly to disturb the balance
between MutY and MMR proteins to support the production
of mutations, which might give growth advantages to these cells
(Debora et al., 2011).
In Streptococcus mutans, an oral pathogen, strains with muta-
tions of mutY were shown to display elevated mutation rates,
increased resistance to killing by acid and oxidative agents as well
as higher virulence compared to the parent strain, suggesting that
loss of a BER factor such as MutY could confer an advantage to
pathogenic organisms (Gonzalez et al., 2012).
MutY and BER in E. coli
Reconstitution experiments with purified proteins from E. coli
revealed, that the presence of Ape1, pol I, and DNA ligase is suf-
ficient to catalyze the entire repair pathway of G:A mismatches
in vitro (Au et al., 1989). Further elucidation of the pathway was
achieved, when Radicella et al. showed that the average repair
tract length initiated by MutY in E. coli is 9–27 nucleotides long,
starting at the removed A, and involved pol I, even though the
involvement of other pols was also evident (Radicella et al., 1993).
This finding was further refined in vitro, when Tsai-Wu et al.
found pol I to be responsible for generating these tracts of 5–12
nucleotides length (Tsai-Wu and Lu, 1994).
MUTYH
MUTYH activity and substrate specificity
The substrate specificities for MUTYH are summarized in
Table 1. The mammalian homolog of MutY, MUTYH, was first
purified from calf thymus and catalyzed removal of A from
A:G, A:8-oxo-G and A:C mismatches (McGoldrick et al., 1995).
Subsequently, expression and purification of the cloned human
protein confirmed its activity to remove A from A:8-oxo-G and
A:G base pairs in vitro, supporting that also the human homolog
is a bona fide DNA glycosylase (Slupska et al., 1999). Purification
of MUTYH from calf liver mitochondria yielded a protein that
complexes with A:8-oxo-G, G:8-oxo-G, and T:8-oxo-G, weakly
with C:8-oxo-G but not with A:G and A:C mismatches and
removed A mispaired with G, C, or 8-oxo-G while weakly remov-
ing G from G:8-oxo-G mispairs (Parker et al., 2000). Purification
of the murine MUTYH revealed strong similarities to MutY
function, even though the intrinsic rates of A removal were
lower than by MutY (Pope and David, 2005). Shinmura and
colleagues reported that both the purified nuclear and mitochon-
drial recombinant isoforms of human MUTYH were active, and
predominantly removed A from A:8-oxo-G mispairs rather than
A:G mispairs under physiological salt concentrations (Shinmura
et al., 2000). MUTYH in human cell extracts was shown to be
more active in binding and glycosylase activity toward A:G mis-
matches than recombinant MUTYH expressed in bacteria (Gu
and Lu, 2001). Furthermore, the authors found this native form
of MUTYH to migrate slower on a non-denaturing polyacry-
lamide gel than recombinant human MUTYH purified from
bacteria. Moreover the native form seems to be phosphorylated,
thus apparently enhancing its glycosylase activity predominantly
on A:G but also on A:8-oxo-G. As the phosphorylation status
of MUTYH did not alter its electric mobility, it was suggested
to be possibly associated with other proteins to account for the
higher apparent molecular weight. Accordingly, co-migration of
APE1 and MUTYH with A:8-oxo-G substrates could be identi-
fied. Ohtsubo et al. found that MUTYH likely also harbors an
activity to remove 2-OH-A (Ohtsubo et al., 2000). Removal of
2-OH-A from opposite 8-oxo-G or G has been described for
murine MUTYH (Pope and David, 2005) and was confirmed for
human MUTYH as well (Ushijima et al., 2005). MUTYH from
S. pombe was able to remove G from G:8-oxo-G mismatches as
efficiently as A from A:8-oxo-G mismatches, and its expression
reduced the frequency of GC→CG transversions in an E. coli
mutY mutant, suggesting it might be involved in the repair of
G:8-oxo-G lesions (Doi et al., 2005).
A:8-oxo-G substrates processed by murine MUTYH were
protected from inappropriate access by OGG1 and APE1, thus
preventing the formation of DSBs (Tominaga et al., 2004).
A study by Miyako et al. found that mitochondrial DNA
(mtDNA) fromHeLa cells could be cleaved by recombinant E. coli
MutY, in contrast to Fpg which has been shown to barely cleave
mtDNA (Driggers et al., 1993; Hegler et al., 1993), and that this
cleavage took place roughly at a rate that was expected to corre-
spond to the amount of 8-oxo-G present in endogenous mtDNA
(Miyako et al., 2000). Suzuki et al investigated the repair of
8-oxo-G in DNA and 8-oxo-dGTP in 293T cells using supF shut-
tle plasmids (Suzuki et al., 2010). While knockdown of OGG1,
MUTYH, NTH1, and NEIL1 all led to a significant increase in
CG→AT transversions caused by the C:8-oxo-G pair in the shut-
tle plasmid, only knockdown of MUTYH resulted in a reduction
in AT→CG transversions induced by 8-oxo-dGTP. In summary,
MUTYH displays remarkable similarity to its bacterial homolog
MutY regarding its activity and substrate specificity.
Localization of MUTYH
The subcellular localization of MUTYH was rather enigmatic for
a long time. A study using expression of tagged proteins in COS-7
cells revealed that MUTYH was mainly transported to the mito-
chondria, which was probably the result of the isoform that was
used (Takao et al., 1998). Follow-up work by the same group
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identified an alternatively spliced transcript differing in exon 1,
leading to the nuclear localization of this variant (Takao et al.,
1999). Ten further isoforms containing unique 5′sequences that
could be grouped into three types were subsequently described,
and suggested to encode multiple authentic MUTYH proteins
(Ohtsubo et al., 2000). Other reports have further discussed the
localization of MUTYH in cells, finding isoforms targeted to the
nucleus (Tsai-Wu et al., 2000; Ichinoe et al., 2004) or the mito-
chondria (Englander et al., 2002; Ichinoe et al., 2004). However,
work still needs to be done to analyze the distribution of iso-
forms to the different subcellular compartments in different cell
and tissue types to clarify this matter further.
Analyzing the distribution of endogenous MUTYH in serum-
stimulated proliferating MRC5 cells with antibodies, Boldogh
et al. reported both nuclear and mitochondrial localization of
MUTYH (Boldogh et al., 2001). The nuclear form co-localized
with BrdU and the proliferating cell nuclear antigen (PCNA)
and, similarly to PCNA, increased 3- to 4-fold to peak during S-
phase compared to G1, whereas levels of OGG1 or MTH1 did not
change during the cell cycle. These studies suggested a role of tar-
geting MUTYH to the replication fork to ensure that its activity is
directed to the newly synthesized template strand. Subsequently,
DNA replication was shown to enhance the MUTYH-dependent
repair of A:8-oxo-G mismatches in vivo, and it was demonstrated
that the interaction with PCNA was critical for the activity of
MUTYH (Hayashi et al., 2002). Taken together, these findings
clearly support a replication-associated function of MUTYH.
MUTYH and DNA damage signaling
Recently, a number of reports have accumulated that link
MUTYH to the DNA damage response and implicate it in apop-
totic signaling. To investigate the contribution of nuclear and
mitochondrial accumulation of oxidative base lesions to the trig-
gering of apoptosis, Oka and colleagues used OGG1 knockout
(ko) cells deficient in the nuclear or mitochondrial form of
MUTYH, respectively (Oka et al., 2008). The accumulation of
single-strand breaks in nuclear DNA triggered PARP-dependent
cell death and could be rescued by depletion of nuclear MUTYH.
The same was true for mitochondria, where MUTYH trig-
gered calpain-dependent cell death by single-strand breaks. These
results suggested that MUTYH catalyzes the formation of single-
strand breaks in both of these DNAs, hence leading to the execu-
tion of apoptosis. Exposure of human cells to sodium nitroprus-
side, an agent that causes 8-oxo-G accumulation in cellular DNA
by acting as an NO donor, led to MUTYH-dependent cell death
that was initiated by oxidized bases in the mitochondrial, but not
the nuclear DNA (Ichikawa et al., 2008). The role of single-strand
breaks generated by MUTYH in the induction of cell death was
further underlined by the finding that synthetic sickness/lethality
mediated by either inhibition of pol β combined with MSH2, a
component of the mismatch repair pathway, or pol γ with MLH1,
both of which led to a nuclear 8-oxo-G accumulation, could be
rescued by silencing of MUTYH (Martin et al., 2010). BER has
been implicated in many different pathological conditions of the
central nervous system (reviewed in Bosshard et al., 2012). A
very recent report implicated MUTYH in degeneration by trig-
gering apoptosis in microglia and neurons through initiation
of single-strand breaks during repair of A:8-oxo-G mismatches
(Sheng et al., 2012). Nuclear accumulation of 8-oxo-G triggered
PARP-dependent apoptosis in microglia, while mitochondrial 8-
oxo-G accumulation led to calpain-dependent apoptosis in neu-
rons. All these findings are in agreement with a model, wherein
the repair of DNAmismatches by MUTYH leads to generation of
toxic single-strand breaks, and thus contributes to cellular death
in case of excessive damage burden (i.e., an amount of DNA dam-
age that surpasses the cellular capacity to further process these
lesions properly). Thus, this model explains, why under condi-
tions of severe damage the absence of MUTYH is beneficial for the
survival of the cells. On the other hand, there are a number of
reports that show that loss of MUTYH actually can sensitize cells
to DNA damaging agents. Along this line, double mutations in
S. pombe MUTYH with RAD1 or, to a lesser extent RAD9, were
shown to enhance the sensitivity of the cells to DNA damaging
agents and hydroxyurea (Jansson et al., 2008). The consequences
of these deficiencies were chromosome segregation defects and
checkpoint failure after UV irradiation, as well as morphologi-
cal defects, even in the absence of DNA damaging agents. This
implicated MUTYH in the repair of a wide range of DNA damage
and linked it to the checkpoint pathway. Under low-dose oxida-
tive stress, MUTYH OGG1 double-ko mouse cells also showed
hypersensitivity to oxidation damage and a reduction of S phase
concomitant with an increase of G2/M phase cells, while the levels
of cell death remained unchanged (Xie et al., 2008). Furthermore,
an increase in centrosome amplifications and formation of mult-
inucleated cells could be observed in the surviving fraction of
the ko cells, suggesting an involvement of MUTYH and OGG1
in the regulation of cell-cycle progression and cell division under
oxidative stress. Further evidence implicating MUTYH in check-
point control came from a study showing that siRNA-mediated
knockdown of MUTYH resulted in a decreased phosphorylation
of ATR and Chk1 upon treatment of HEK293 cells with HU or
UV (Hahm et al., 2011). Concomitantly, the authors observed an
increase in the phosphorylation of Cdk2 as well as the amount of
the Cdc25A phosphatase, suggesting that MUTYH was involved
in activation of the DNA damage response.
Thus, there seems to be growing evidence that implicates
MUTYH to be an important factor in the cellular response to
oxidative stress and inflammatory conditions by an involvement
in cell death signaling (as discussed in Oka and Nakabeppu,
2011). Along these lines, MUTYH has been suggested to play
a role in mitochondrial dysfunction in the pathogenesis of
Parkinson’s disease (Fukae et al., 2007; Nakabeppu et al., 2007).
However, it still remains to be clarified how MUTYH can initiate
apoptosis of cells in some instances, while it seems to protect from
apoptosis in others.
Impact of MUTYH knockout on oxidative DNA damage and
tumorigenesis in vivo
The data on cells and mice with biallelic deletion of MUTYH are
somewhat discrepant.MUTYHko embryonic stem cells displayed
a mutator phenotype, but did not show any hypersensitivity
toward oxidative stress induced by H2O2 or menadione (Hirano
et al., 2003). A study with mutyh−/− knockout mice by Xie et al
revealed no significant increase in survival or tumor incidence
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after 14 months, suggesting that MUTYH deficiency is not suf-
ficient to cause a tumor-predisposition (Xie et al., 2004). This
study also showed that combined ko of MUTYH with OGG1
led to a decrease in life span and increased tumor formation for
double ko mice compared to single ko. Interestingly, 75% of the
lung tumors showed an activating GC→TA transversion muta-
tion at codon 12 of K-ras, a feature that is often detected in
MUTYH-associated polyposis (MAP) tumors, but none in the
p53 gene or in the adjacent normal tissues. Additional heterozy-
gosity forMsh2 (mutyh−/− ogg1−/− msh2±) did not inflict on the
total tumor incidence but accelerated malignant lung and ovarian
tumor formation in the mutyh−/− ogg1−/− background. A com-
plete knockout of Msh2 to generate triple ko (mutyh−/− ogg1−/−
msh2−/−) further increased tumor incidence and decreased sur-
vival time, but did not differ from the phenotype displayed by
msh2−/− single knockouts. This was suggested to be due to the
strong mutator phenotype of msh2−/− mice that might mask
additional difference caused bymutyh−/− and ogg1−/−.
Spontaneous mutagenesis in the small intestine of ogg1−/−
and mutyh−/− ogg1−/− double deficient mice at the age of
4–5 weeks using a transgene reporter revealed increased muta-
tions in the double-ko’s but not in the ogg1−/− mice (Isogawa,
2004). Furthermore, the GC→TA mutation frequency increased
in mutyh−/− and in ogg1−/−and a cooperative increase could be
observed in mutyh−/− ogg1−/−, suggesting a cooperative func-
tion between OGG1 and MUTYH to prevent 8-oxoG-related
mutagenesis. Russo et al. also reported an additive effect in
mutyh−/− ogg1−/− on the age-dependent increase in 8-oxo-G
levels in lung and small intestine compared to the single ko’s
(Russo et al., 2004). Strikingly, these tissues were identical with
the ones that showed increased cancer incidence in mutyh−/−
ogg1−/− mice in the study by Xie et al. (2004). MUTYHdeficiency
in a background of APCmin/+ mice led to the occurrence of stop-
codons in the APC gene by induction of CG→AT transversion
mutations and thus promoted intestinal tumorigenesis (Sieber
et al., 2004).
In 2007 a study reported an increased susceptibility to spon-
taneous and stress-induced tumorigenesis in a large cohort of
mutyh−/− mice kept for 18 months, strongly contradicting data
on mutyh−/− obtained by different groups thus far (Sakamoto
et al., 2007). This suggested that presence of a MUTYH deficiency
is sufficient to predispose for malignancies of the intestinal tract,
such as lymphoma and adenoma. More impressively still, oral
KBrO3 treatment of mutyh−/− mice led to a dramatic increase
in CG→AT transversion mutations and small intestinal tumors.
The authors claimed that the tumor-prone phenotype might have
been missed earlier due to genetic differences in the mouse strains
and the older age at which the tumor burden was evaluated in
their study. This was in line with the fact that many of the stud-
ies with mutyh−/− mice have been reporting a strong tendency
toward age-dependent accumulation of 8-oxo-G in tissues. In
general, in light of the huge complexity of the disease, it can
be debated, whether mice are useful cancer models to compare
with the human disease, due to the entirely different life span,
metabolism, inbreeding status and many other aspects.
As noted above, the combination mutyh−/− and msh2−/−
did not greatly affect the mutation rate. However, the loss of
mutyh−/− combined with msh2−/− significantly increased the
amount of oxidative DNA damage in several organs compared to
msh2−/− mice, suggesting an independent contribution of both
genes to genetic maintenance (Russo et al., 2009). Surprisingly,
the development of metastasizing lymphoma and the time of
death were significantly delayed in the mutyh−/−msh2−/− mice
compared to msh2−/−, suggesting that the cancer-prone pheno-
type of the double knockouts depends substantially on the activity
of MUTYH (Russo et al., 2009). The relationship of MUTYH and
MMR is reviewed in more detail in Russo et al. (2007).
In a mouse model of ulcerative colitis MUTYH was shown to
play a major role in propagating the inflammatory response that
lead to the onset of chronic colitis (Casorelli et al., 2010). Taken
together, all the data analyzing the function of MUTYH in vivo
strongly supports the idea that MUTYH-mediated correction
of A:8-oxo-G mispairs plays an important role in the main-
tenance of genetic integrity and protects cells from malignant
transformation.
THE MUTYH/POL λ BASE-EXCISION REPAIR PATHWAY
By catalyzing the excision of the mispaired A from A:8-oxo-G
base pairs, MUTYH paves the way for a subsequent repair that
ultimately reconstitutes an undamaged C:G base pair. MUTYH-
initiated repair has been shown to involve a replication-coupled
long-patch BER (LP-BER) pathway (Matsumoto, 2001; Parker
et al., 2001; Yang et al., 2001; Parlanti et al., 2002). Along this
line, a SP-BER pathway initiated by MUTYH was shown to be
futile, because it uniquely generated A:8-oxo-G base pairs instead
of the correct C:8-oxo-G base pairs, indicating that canonical
MUTYH-initiated BERmust proceed by the LP-BER sub-pathway
(Hashimoto et al., 2004). For a long time it was unclear, which
pol was capable of faithfully inserting a correct C opposite 8-oxo-
G, as most examined pols showed significant error-prone bypass
of 8-oxo-G (Shibutani et al., 1991; Pinz et al., 1995; Efrati et al.,
1999; Prakash et al., 2000; Einolf and Guengerich, 2001; Vaisman
and Woodgate, 2001; Krahn et al., 2003; Hsu et al., 2004). In
2007, our laboratory proposed that pol λ, together with its cofac-
tors PCNA and replication protein A (RPA), inserts 1200-fold
more efficiently the correct C opposite 8-oxo-G than the incorrect
A (Maga et al., 2007). Furthermore, experiments with extracts
from mouse embryonic fibroblasts (MEFs) deficient for pol λ
suggested an important role of pol λ in bypass of 8-oxo-G. The
importance of PCNA and RPA to determine the pol selection at
8-oxo-G lesions was further analyzed in a follow-up study. The
two proteins were found to act as molecular switches to acti-
vate pol λ-dependent correct 8-oxo-G bypass and to repress the
more error-prone pol β-dependent bypass (Maga et al., 2008).
Subsequently, we showed that the MUTYH-initiated error-free
LP-BER pathway involves pol λ (Maga et al., 2008; Van Loon
and Hubscher, 2009), as depicted in detail in Figure 1. Herein,
the monofunctional MUTYH excises the promutagenic A from
A:8-oxo-G base pairs. This is followed by incision of the phospho-
diester backbone 5′ to the AP site by APE 1 that generates a 3′OH
and a 5′dRP moiety, respectively. Thereafter, in the presence of
RPA and PCNA, pol λ incorporates the correct C opposite 8-oxo-
G and further elongates the primer by one more nucleotide (nt)
downstream, thus generating a short 1-nt 5′ flap. This overhang
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is processed by flap endonuclease 1 (Fen1), resulting in a product
that can be ligated by DNA ligase I. The resulting C:8-oxo-G base
pair is then substrate for the canonical OGG1-initiated SP-BER as
discussed above.
MUTYH-INTERACTING PROTEINS
All DNAdamage repair pathways have to be tightly coordinated to
ensure proper repair and to avoid the generation of cytotoxic and
mutagenic intermediates. Protein-protein interactions either reg-
ulate the repair by recruitment of proteins to sites of DNAdamage
or modulate the catalytic activity of already bound enzymes.
MUTYH is interacting with proteins associated with the BER
pathway, DNA replication and cell cycle checkpoints (Table 2).
The first interaction partner of MUTYH was the endonuclease
Ape1 (Parker et al., 2001; Yang et al., 2001). Ape1 stimulates the
glycosylase activity of MUTYH independently from its own activ-
ity; a catalytically dead mutant of Ape1 still enhanced the cleavage
efficiency of MUTYH on damaged DNA templates (Yang et al.,
2001). Thus, the stabilization of the MUTYH-DNA complex was
sufficient to enhance the repair capacity. Additionally, MUTYH
and Ape1 were both recruited into a complex with A:8-oxo-G
containing DNA in HeLa cell extracts (Gu and Lu, 2001). The
interaction between the two proteins was suggested to be impor-
tant to prevent the release of cytotoxic AP sites (Luncsford et al.,
2010). MUTYH was found to interact with pol λ, as discussed
above (Van Loon andHubscher, 2009). Furthermore, the interac-
tion of MUTYH with pol λ was enhanced by phosphorylation of
pol λ by Cdk2/cyclinA (Markkanen et al., 2012b,c).
Gu et al identified the mismatch repair protein MSH6 as
further interaction partner of MUTYH, and MSH6 regulated
MUTYHby stimulating its glycosylase activity and binding capac-
ity to A:8-oxo-G containing DNA (Gu et al., 2002).
MUTYH interacts with PCNA and RPA under conditions
of unperturbed DNA replication. It was suggested that, upon
encountering DNA damage, MUTYH switches to interact with
the heterotrimeric ring-like molecule Rad 9, Rad1, and Hus 1,
called the 9-1-1 complex (Parker et al., 2001; Shi et al., 2006).
Consistent with these findings, MUTYH co-localized with PCNA
at replication foci in untreated cells (Boldogh et al., 2001). Also,
replication was a prerequisite for MUTYH mediated repair to
occur (Hayashi et al., 2002). The interaction site with PCNA was
mapped to a conserved region within the MutY family, reflecting
the importance of this interaction since PCNA directs MUTYH to
the daughter strand where it excises a recently inserted mispaired
A from A:8-oxo-G base pairs (Slupska et al., 1999). This direc-
tionality could also be the mechanism to make sure that MUTYH
does not excise erroneously A from a base pair where 8-oxo-dGTP
has been inserted opposite a templating (and thus correct) A. The
interaction ofMUTYHwith PCNA and the structurally-related 9-
1-1 complex was also confirmed in S. pombe (Parker et al., 2001;
Chang and Lu, 2002, 2005; Shi et al., 2006; Luncsford et al., 2010).
Interestingly, it was shown that even if the SpMUTYH does not
have a perfect PCNA binding motif (Chang and Lu, 2005), cross-
binding between the yeast and the human isoforms is possible and
mutations within the PCNA binding domain impair the capabil-
ity of MUTYH to repair A:8-oxo-G mismatches in yeast (Chang
and Lu, 2002).
The 9-1-1 complex acts as a DNA damage sensor, blocks the
cell cycle and simultaneously stimulates BER to allow repair to
be completed before the DNA is replicated. The human MUTYH
interacts with the h9-1-1 complex via binding to hRad1 and
hHus1, but not to hRad9 (Shi et al., 2006). The glycosylase activ-
ity of MUTYH was stimulated by this interaction if 9-1-1 was
present in a substantial molar excess. Treatment of cells with
H2O2 or ionizing irradiation enhanced this interaction, support-
ing the hypothesis that 9-1-1 replaces PCNA in stress situations
(Shi et al., 2006). Luncsford et al. identified the interdomain con-
nector (IDC) of MUTYH to mediate the binding to 9-1-1 by
providing a stabilized docking interface and proved the impor-
tance of the interaction by showing that mutations within this site
decrease the repair of oxidative damage in vivo (Luncsford et al.,
2010).
Partial interchangeability was observed between human and
S. pombe homologs of these proteins, and enhanced glycosylase
Table 2 | Interaction partners of MUTYH.
Interaction partner Species Interaction site in MUTYH Stimulatory effect
Ape1 human 259–318 (Parker et al., 2001) Glycosylase activity (Yang et al., 2001)
MSH6 human 232–254 (Gu et al., 2002) Glycosylase activity DNA binding (Gu et al., 2002)
Pol λ human Van Loon and Hubscher, 2009; Markkanen et al., 2012c
40–130 (Dorn et al., unpublished results)
n.d.
PCNA human 505–527 (Parker et al., 2001), F518/F519 (Chang and Lu, 2002) n.d.
S. pombe 438–445 (Chang and Lu, 2002) n.d.
9-1-1 human 295–350 (Shi et al., 2006)
V315, E316 (Shi et al., 2006; Luncsford et al., 2010)
Glycosylase activity (Chang and Lu, 2005),
interaction increased after IR (Shi et al., 2006)
S. pombe 245–293 (Chang and Lu, 2005)
I261, E262
Glycosylase activity (Chang and Lu, 2005),
interaction increased after H2O2 treatment
RPA human 6–32 (Parker et al., 2001) n.d.
ATR human n.d. Checkpoint mediator? (Hahm et al., 2011)
n.d., not determined.
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activity of S. pombe MUTYH was found with human Hus1
and the S. pombe 9-1-1. Human MUTYH was also observed
to co-localize with Rad9 in cells treated with H2O2, suggest-
ing that BER by MUTYH could be modulated by 9-1-1. Further
work in S. pombe showed a decrease in repair of oxidative DNA
damage in vivo when the interaction of MUTYH with 9-1-1
was disrupted, suggesting that this interplay significantly con-
tributes to the response to oxidative stress (Luncsford et al., 2010).
Also, MUTYH could be co-immunoprecipitated with ATR from
human cells, possibly implicating MUTYH in ATR-mediated
checkpoint execution (Hahm et al., 2011).
MUTYH from S. pombe was found to interact with Hst4, a
histone deacetylase involved in silencing of genes and mainte-
nance of genomic integrity, which seemed to regulate the levels of
Hst4 after oxidative stress (Chang et al., 2011). Hst4 was further
shown to interact also with the 9-1-1 complex. The association of
MUTYH with telomeres was increased after oxidative stress and
by deletion of Hst4, and Hst4 bound to telomeres decreased after
oxidative stress, concomitant with a decrease in total Hst4 levels.
Finally, MUTYH association with telomeres was increased in a
Hst4 deletion background in the presence of chronic DNA dam-
age caused by the lack of Hst4. Therefore, MUTYH seemed to reg-
ulate repair of telomeres by orchestrating the functions of 9-1-1
and Hst4. Finally, the WRN helicase/exonuclease was recently
shown to promote MUTYH-initiated LP-BER of A:8-oxo-G mis-
matches by pol λ (Kanagaraj et al., 2012).
REGULATION OF MUTYH
REGULATION OF MUTYH LEVELS
So far, only a limited amount of studies has been performed con-
cerning the regulation of MUTYH levels. Respiratory hypoxia
caused a strong increase in mtDNA damage and also in expres-
sion of MUTYHmRNA in rat brain (Englander et al., 2002). This
suggested that the increase denoted an adaptive mechanism for
protection of neuronal DNA from oxidative injuries stemming
from an imbalance in metabolism. Follow-up work by the same
group identified specific MUTYH isoforms exclusive to brain tis-
sue in rats, that were targeted to the mitochondria and some of
them were inducible upon respiratory hypoxia (Englander et al.,
2002). The divergence in the N-terminus between the different
MUTYH isoforms was found to influence their excision rates
and the processing of AP sites (Ma et al., 2004). In mononu-
clear blood cells MUTYH levels were neither altered by hypoxia
nor by inhalation of 10% oxygen for 2 h and the subsequent
reoxygenation period in healthy human subjects, even though
DNA strand breaks and oxidatively damaged purines accumu-
lated by this treatment (Risom et al., 2007). MUTYH, together
with SMUG1, was regulated transcriptionally by p73, a member
of the p53 protein family, through DNA damage induction by
bile acid exposure, suggesting that this interplay regulates DNA
damage repair (Zaika et al., 2011).
A comparison of embryonic stem cells to more differenti-
ated cells did not reveal any impact on the mRNA levels of
MUTYH, in contrast to OGG1, which decreased upon differenti-
ation (Kuboyama et al., 2011). Alimentary supplementation with
quercetin, a plant-derived flavonoid that has been attributed with
anticarcinogen, was found to enhance the expression of MUTYH
in the distal colon mucosa of rats (Dihal et al., 2008). And finally,
overexpression of hepatitis B virus X (HBx) was shown to increase
8-oxo-G levels in HepG2 cells, and to decrease the transcript lev-
els of MUTYHα mRNA, while not affecting mRNA of OGG1,
suggesting that this may be linked to the development of hepa-
tocellular carcinoma which is associated to HBx infection (Cheng
et al., 2009).
REGULATION OF MUTYH BY POSTTRANSLATIONALMODIFICATIONS
Very little is known about the regulation of MUTYH by post-
translational modifications (PTM) (Table 3). Findings from Gu
et al. showed that MUTYH could be phosphorylated in vitro
by different protein kinases (Gu and Lu, 2001). Comparison of
the activity of native MUTYH from human cell extracts with in
recombinant MUTYH purified from bacteria revealed a dramatic
difference in the glycosylase activity, probably due to the phos-
phorylation state of the proteins. Indeed, the dephosphorylation
of native MUTYH led to a tremendous loss of function on A:G or
A:8-oxo-G mismatch containing templates. Differences in activ-
ity were also described for recombinant MUTYH expressed in
bacteria or insect cells (Kundu et al., 2010). Mass spectrometric
analysis confirmed S524 to be phosphorylated in the more active
MUTYH, expressed in insect cells. Further functional studies
usingwt, phosphomimetic, or phosphodeficientmutants revealed
an important role of S524 in substrate recognition and binding to
DNA.
A defect in phosphorylation of MUTYH was also found to
cause a mutator phenotype in different microsatellite stable col-
orectal cancer cell lines (Parker et al., 2002). All tested cell lines
that showed elevated 8-oxo-G levels showed a decline in repair
of A:8-oxo-G mismatches. While the sequencing of the MUTYH
locus in these cells did not reveal any mutations, the mRNA and
protein levels of MUTYH were decreased. In a subsequent study
the same authors could demonstrate that a loss of MUTYH phos-
phorylation by PKC was responsible for the observed increase
in 8-oxo-G causing the mutator phenotype (Parker et al., 2003).
The 8-oxo-G repair capacity in MUTYH impaired cell extracts
could be restored by complementation with PKC, PKA or casein
kinase II. Furthermore, the same effect could be achieved by treat-
ment with the PKC activator phorbol-12-myristate-13-acetate
(PMA). In contrast to that, no effect in cell extracts fromMUTYH
proficient cells occurred, indicating that MUTYH was already
Table 3 | Posttranslational modifications of MUTYH.
Posttranslational Site of Kinase Stimulatory
modification modification effect
Phosphorylation
(Gu and Lu, 2001)
n.d. n.d. Glycosylase activity
Phosphorylation
(Parker et al., 2002,
2003)
n.d. PKC
PKA
Casein Kinase II
Glycosylase activity
Phosphorylation
(Kundu et al., 2010)
S524 n.d. DNA-binding
n.d., not determined.
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phosphorylated at a basal level in these cell lines. Consistent
with these findings, MUTYH was a substrate for PKC in vitro.
Finally, MUTYH purified directly from cell extracts treated with
PMA showed an elevated capacity in the repair of A:8-oxo-G
mismatches. So far it has not been elucidated whether phospho-
rylation only interferes with the catalytic activity of MUTYH,
regulates its interaction with other proteins, or leads to a different
subcellular localization. Since PKC can be stimulated by oxidative
stress (Klein et al., 2000), it is possible that the phosphorylation-
mediated regulation of MUTYH presents an adaptive response to
DNA damage.
Taken together, it would be very interesting to investigate the
regulation of MUTYH in more detail to get a better understand-
ing how the different players of the 8-oxo-G repair machinery are
controlled to protect cells from oxidative stress of endogenous or
exogenous sources.
INVOLVEMENT OF MUTYH IN DISEASE
MAP (MUTYH ASSOCIATED POLYPOSIS)
Familial adenomatous polyposis (FAP) is an autosomal dominant
disease characterized by the formation of hundreds to thousands
of adenomatous polyps in the colons and rectums of the affected
patients (reviewed in Fearnhead et al., 2001). It is caused by
a germline mutation in the adenomatous polyposis coli (APC)
gene, mutations that are also responsible for 80% of the sporadic
colorectal tumors. In 2002, Al-Tassan and co-workers studied a
British family with multiple colorectal adenoma and carcinoma,
but failed to detect a mutation in the APC gene (Al-Tassan et al.,
2002). Closer analysis of the patientmaterial revealed an increased
tendency of somatic CG→AT transversion mutations in the APC
gene, which is consistent with 8-oxo-G mediated mutagenesis.
This observation led the authors to dissect the three enzymes
that work synergistically to counteract 8-oxo-G mediated muta-
genesis, namely OGG1, MUTYH, and MTH. Sequencing of the
respective genes revealed two non-conservative mutations in the
MUTYH gene, Y165C (through an A→G transition) and G382D
(through a G→A transition), while no pathogenic changes were
observed in the OGG1 and MTH genes. The two mutations were
found to reduce the activity of E. coli mutY to remove A from
G:A mismatches by 98% and 86%, respectively, suggesting that
a defect in MUTYH activity was the reason for the accumulated
mutations in the patients and thus responsible for the APC-like
phenotype. Subsequent work revealed that these mutations not
only compromise the bacterial mutY, but also caused a decrease in
the activity of human MUTYH for excision of A opposite 8-oxo-
G, which nicely correlated with the tumor phenotype (Al-Tassan
et al., 2002; Chmiel et al., 2003; Pope and David, 2005). Further
investigation led to the identification of seven other unrelated
patients with colorectal adenomas or carcinomas that showed a
bias of CG→AT transversion mutations to be carriers of biallelic
germline mutations for MUTYH (Jones et al., 2002). This disor-
der is the only colorectal cancer form inherited in an autosomal
recessive mode and is now commonly referred to asMAP, or infre-
quently also as FAP2 (http://www.omim.org). The prevalence of
MAP is estimated to be around 1% of all colorectal cancer cases
(Enholm et al., 2003; Croitoru et al., 2004; Fleischmann et al.,
2004; Wang et al., 2004; Peterlongo et al., 2005; Webb et al., 2006;
Kury et al., 2007; Cleary et al., 2009) andMUTYHmutations have
been found in 7% (Filipe et al., 2009), and 10% (Pezzi et al.,
2009) of FAP patients and 40% of AFAP patients, respectively
(Filipe et al., 2009). The lifetime-cancer risk is assessed to 80%
for colon cancer and 4% for duodenal cancer (Jasperson et al.,
2010). Even though MAP is a rather recently discovered disease,
many germline mutations in addition to the two found by Al-
Tassan et al have been described so far. This is reflected in the
abundance of literature investigating different single-nucleotide
polymorphisms and their relevance to cancer development has
been thoroughly reviewed in Cheadle and Sampson (2007) and
Poulsen and Bisgaard (2008). Interestingly, other than MUTYH,
no association of further genes involved in BER or the repair of
oxidative DNA damage with a multiple colorectal adenoma phe-
notype has been found so far (Dallosso et al., 2008). Interestingly
though, work by the Sweasy group has found that the POLB
gene is mutated in many colorectal cancers, suggesting that at
least some of these mutations may lead to compromised BER
function in the affected tissues (Donigan et al., 2012; Nemec
et al., 2012). MAP patients have been reported to be more prone
also to extraintestinal tumors such as ovarian, bladder, skin, and
breast cancer. For an overview of all extracolonic manifestations
of MAP-patients, please refer to this recent review (Nielsen et al.,
2011). For further clinical features, there are excellent recent
reviews available (Jasperson et al., 2010; Nielsen et al., 2011).
Several mutations in MUTYH associated with MAP were found
to significantly enhance the spontaneous mutator phenotype of
patient’s lymphoblasts under conditions of oxidative stress and
to accumulate 8-oxo-G in the DNA, underlining the role of
MUTYH in the pathogenesis of this disease (Ruggieri et al., 2012).
However, for many of the mutants it is unclear how the mutation
affects its activity, and more work is needed to clarify their exact
contribution to the disease.
EQUINE CEREBELLAR ABIOTROPHY
Interestingly, MUTYH has been suggested to be involved in the
pathogenesis of equine cerebellar abiotrophy, a neurological dis-
ease found in Arabian horses, as indicated by a SNP in the GATA2
binding region of the MUTYH promoter (Brault et al., 2011).
Whether there is a real causative role and what mechanisms are
behind it, remains to be elucidated by further studies.
CONCLUSIONS AND PERSPECTIVES
The MUTYH DNA glycosylase is a remarkable enzyme since it
has the specificity to remove an undamaged DNA base from a
mismatch such as an A:8-oxo-G. It is found throughout evolution
from bacteria to human, suggesting an essential role in prevent-
ing mutations arising from oxidative damage to the DNA. During
the last three decades, our knowledge about how MUTYH func-
tions has grown substantially. We now understand quite in detail
how MUTYH acts catalytically, and the structures of prokary-
otic and eukaryotic enzymes have been identified. However, the
functional details of the at least 10 isoforms of MUTYH, are
far from being unequivocally clarified. MUTYH acts together
with pol λ in the so-called MUTYH/pol λ pathway that can
replace a promutagenic A paired to an 8-oxo-G with a correct C.
The interaction with the moving platforms PCNA and the 9-1-1
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complex is apparently very important for the proper spatial and
temporal engagement of MUTYH on the DNA, and there espe-
cially in the context of chromatin. So far, very little is known about
the regulation of MUTYH, which is at least in part likely achieved
by PTM. Phosphorylation as an important PTM contributes to
regulate the activity of MUTYH. It is likely that other PTM’s, such
as ubiquitination, will be identified that govern the temporal (i.e.,
during the cell cycle) as well as the spatial (i.e., the subcellular
localization) distribution of MUTYH. Also, the fact that muta-
tions in MUTYH are identified in diseases of human and animals
shifts this enzyme more and more into the focus of translational
medicine. In the future, it will be of interest to understand more
about the subcellular localization and specific functions of the
different isoforms of MUTYH. Also, the exact regulation of the
activity, stability, and localization of this enzyme is likely to yield
many novel insights. Finally, we are anticipating further clarifica-
tion of the functional roles of the different mutations in MUTYH
associated with MAP.
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